Skip to main content
AkademIndex

Products

For developers

AkademBaseOpen API for the ecosystem

Bal Sanghera

1 works

  1. Young Adults Aged 18 to 30 Years with Hodgkin Lymphoma Can Tolerate a Modified Version of the Combined Modality German Paediatric HD95 Protocol with Minimal Neurotoxicity and Excellent Outcome. Results of the UK NCRN 18–30 Study (CRUK/08/012)

    Kirit M. Ardeshna, Peter Hoskin, Paul Smith +15

    ArticleAcute Lymphoblastic Leukemia researchBlood20120 citations
    ABI